Cirrhotic Multiorgan Syndrome (Q38538183)

3 September 2017

1 reference

title

Cirrhotic Multiorgan Syndrome (English)

1 reference

3 September 2017

Søren Møller

1

1 reference

3 September 2017

Flemming Bendtsen

series ordinal

2

1 reference

3 September 2017

26 June 2015

1 reference

Digestive Diseases and Sciences

3 September 2017

1 reference

3 September 2017

60

1 reference

3 September 2017

11

1 reference

3 September 2017

3209-3225

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-015-3752-3

3 September 2017

0 references

cites work

Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Prognostic indicators of survival in patients with compensated and decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Management of critically-ill cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute-on-chronic liver failure: a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Necrotic death pathway in Fas receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Quantitative histological-hemodynamic correlations in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatic fibrosis, stellate cells, and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Complications of cirrhosis. I. Portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Vasoactive substances in the circulatory dysfunction of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cardiovascular complications of cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Endothelial dysfunction in the regulation of cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Water and sodium retention in edematous disorders: role of vasopressin and aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Circulatory function and hepatorenal syndrome in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Beta-blockers in portal hypertension: new developments and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Bacterial infections in end-stage liver disease: current challenges and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Management of bacterial infections in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Pathological bacterial translocation in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Spontaneous bacterial peritonitis: recent guidelines and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Bacterial translocation (BT) in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Severe sepsis in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Inflammation and portal hypertension - the undiscovered country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

New insights into cirrhotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cardiac electrophysiological abnormalities in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cirrhotic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The cardiac response to exercise in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Therapy insight: Cirrhotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

QT interval prolongation in liver cirrhosis: innocent bystander or serious threat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Interactions of the heart and the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Does cirrhotic cardiomyopathy exist? 50 years of uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Autonomic dysfunction in cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Arterial hypoxaemia in cirrhosis: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Pulmonary-Hepatic vascular Disorders (PHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Therapeutic options in pulmonary hepatic vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Pulmonary complications in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts: role of increased pulmonary artery pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hemodynamic features and impaired arterial oxygenation in patients with portopulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hemodynamics and survival of patients with portopulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Portopulmonary hypertension: from diagnosis to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Portopulmonary hypertension and the issue of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Portopulmonary hypertension: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Evaluation of renal function in patients with cirrhosis: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The cardiorenal link in advanced cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute kidney injury in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute kidney injury in patients with cirrhosis: perils and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Kinetics of Hepatitis B virus load during haemodialysis sessions and α-interferon: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute-on chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Renal failure and cirrhosis: a systematic review of mortality and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Renal failure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Decreased effective blood volume in edematous disorders: what does this mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Update on adrenal insufficiency in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cerebral Blood Flow and Liver Function in Patients with Encephalopathy due to Acute and Chronic Liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Regional cerebral blood flow and cognitive function in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Pathophysiological changes in cerebral circulation, oxidative metabolism and blood-brain barrier in patients with acute liver failure. Tailored cerebral oxygen utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Autonomic dysfunction and impaired cerebral autoregulation in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute changes in cerebral blood flow and metabolism during portasystemic shunting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Acute-on-chronic liver failure: the heart and systemic hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Experience with inhaled iloprost and bosentan in portopulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3752-3

Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging

21 January 2018

1 reference

12 December 2020

Changes in cardiovagal baroreflex sensitivity are related to increased ventricular mass in patients with liver cirrhosis

1 reference

12 December 2020

Portopulmonary hypertension

1 reference

12 December 2020

Hepatopulmonary syndrome

1 reference

12 December 2020

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis

1 reference

12 December 2020

Cardiac and proinflammatory markers predict prognosis in cirrhosis

1 reference

12 December 2020

Adrenal function in cirrhosis: the pendulum swings

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender

1 reference

12 December 2020

Screen for portopulmonary hypertension, especially in liver transplant candidates.

1 reference

12 December 2020

Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome

1 reference

12 December 2020

Hemodynamic studies in acute-on-chronic liver failure

1 reference

12 December 2020

Hepatopulmonary syndrome

1 reference

12 December 2020

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features

1 reference

12 December 2020

Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis

1 reference

12 December 2020

Distinctive clinical features of portopulmonary hypertension

1 reference

12 December 2020

Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis

1 reference

12 December 2020

Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique

1 reference

12 December 2020

AASLD practice guidelines: Evaluation of the patient for liver transplantation

1 reference

12 December 2020

High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients

1 reference

12 December 2020

Cardiac alterations in cirrhosis: reversibility after liver transplantation

1 reference

12 December 2020

Cerebral blood flow autoregulation and transcranial Doppler sonography in patients with cirrhosis.

1 reference

12 December 2020

Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems

1 reference

12 December 2020

Hepatopulmonary syndrome

1 reference

12 December 2020

Hepatopulmonary syndrome: update on pathogenesis and clinical features

1 reference

12 December 2020

Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation

1 reference

12 December 2020

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites

1 reference

12 December 2020

The impact of organ dysfunction in cirrhosis: survival at a cost?

1 reference

12 December 2020

Relationship between NT-proBNP and cardio-renal dysfunction in patients with advanced liver cirrhosis

1 reference

12 December 2020

Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices

1 reference

12 December 2020

Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats

1 reference

12 December 2020

Glomerular filtration rate is an independent factor of mortality in patients with decompensated cirrhosis

1 reference

12 December 2020

Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems

1 reference

12 December 2020

Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis

1 reference

12 December 2020

The changing role of beta-blocker therapy in patients with cirrhosis

1 reference

12 December 2020

The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure

1 reference

12 December 2020

Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease

1 reference

12 December 2020

Single-centre validation of the EASL-CLIF Consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis

1 reference

12 December 2020

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis

1 reference

12 December 2020

Treatment of acute variceal bleeding

1 reference

12 December 2020

Bacterial translocation in liver cirrhosis: site and role in fibrogenesis

1 reference

12 December 2020

The relationship of heart rate variability with severity and prognosis of cirrhosis

1 reference

12 December 2020

Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study

1 reference

12 December 2020

Hepatorenal syndrome and novel advances in its management

1 reference

12 December 2020

Hepatopulmonary syndrome: favorable outcomes in the MELD exception era

1 reference

12 December 2020

Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C

1 reference

12 December 2020

Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases.

1 reference

12 December 2020

Betablockers induce cardiac chronotropic incompetence

1 reference

12 December 2020

QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium

1 reference

12 December 2020

Cardiac sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to autonomic and cardiac function

1 reference

12 December 2020

Role of the liver in splanchnic extraction of atrial natriuretic factor in the rat

1 reference

12 December 2020

Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension

1 reference

12 December 2020

Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure

1 reference

12 December 2020

10.1007/S10620-015-3752-3

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1052952842

0 references

Fatcat ID

release_wsdhm5snvvhhdlqyx2dzfweyyi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wsdhm5snvvhhdlqyx2dzfweyyi

24 November 2022

mapped directly with Wikidata item

1 reference